Table 1.
MIDY mutations |
Ages of onset |
Original diagnosis |
References |
|||
---|---|---|---|---|---|---|
Nomenclature by peptide chain |
Nomenclature by preproinsulin a.a. |
|||||
Signal Peptide |
R(SP6)C or H | R6C or H | 15-65yr1 | MODY1 | 50,56,60 | |
A(SP23)S | A23S | 6 yr | Type 1 | 66 | ||
A(SP24)D | A24D | most <6 mo2 | Neonatal DM2 | 49,50,62 | ||
| ||||||
Insulin B Chain |
H(B5)D | H29D | <6 mo | Neonatal DM | 50 | |
L(B6)M. V. or P | L30M, V or P | <6 mo or 17-38 yr3 | Neonatal DM or MODY3 | 53,60 | ||
G(B8)S or R | G32S or R | most <6 mo4 | Neonatal DM or Type 14 | 49-50,54,66 | ||
L(B11)P | L35P | <6 mo | Neonatal DM | 50,53 | ||
LY(B15,16)H | L39Y delinsH | <6 mo | Neonatal DM | 53 | ||
C(B19)G | C43G | most <6 mo5 | Neonatal DM5 | 49-50 | ||
R(B22)Q | R46Q | 17-24 yr | MODY | 51,56 | ||
G(B23)V | G47V | <6 mo | Neonatal DM | 49-50 | ||
F(B24)C | F48C | <6 mo | Neonatal DM | 49-50 | ||
| ||||||
B-C junction |
R(Cpep -2)C | R55C | <6 mo or 8-37 yr | Type 1 or MODY | 51,60 | |
C-Peptide | G(Cpep28)R | G84R | <6 mo | Neonatal DM | 50 | |
C-A junction |
R(Cpep+2)C | R89C | most <6 mo6 | Neonatal DM6 | 49-54 | |
| ||||||
Insulin A Chain |
G(A1)C | G90C | <6 mo | Neonatal DM | 49-50 | |
C(A6)Y | C95Y | <6 mo | Neonatal DM | 53 | ||
C(A7)Y or S | C36Y or S | <6 mo | Neonatal DM | 49-50,62,55 | ||
S(A12)C | S101C | <6 mo | Neonatal DM | 50 | ||
Y(A14)C | Y103C | <6 mo | Neonatal DM | 14 | ||
Y(A19)C or Stop | YlOSC or stop | <6 mo | Neonatal DM | 49-50,53 |
Age of onset 5 wk - 7 y in 3 members of the same family (50)
Proband’s mother, age 68, carries mutation without DM (60)
Age of onset 5 mo - 22 y in 4 members of the same family(50)
Proband’s father developed diet-controlled type 2 DM beginning at age 30 (49)
Three family members developed DM age 2 - 4 y (51).
The native SP23 of chimpanzee preproinsulin is Ser. In the cartoon on the right, the normal position of Cys residues is overlaid in pink; disulfide pairs shown with red lines
MIDY mutation sites overlaid in green.